Armistice Capital, Llc Avalo Therapeutics, Inc. (AVTX) insider trading activity

Armistice Capital, LLC is > 10% Shareholder of Avalo Therapeutics, Inc.. Currently has a direct ownership of 39.1 Million shares of AVTX, which is worth approximately $380 Million. The most recent transaction as insider was on Apr 18, 2018, when has been sold 81,544 shares (Common Stock) at a price of $3.41 per share, resulting in proceeds of $278,065. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 39.1M

0% 3M change

0% 12M change

Total Value Held $380 Million

ARMISTICE CAPITAL, LLC Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Apr 18 2018	BUY Open market or private purchase	$278,065 $3.41 p/Share	81,544 Added 0.5%	16,200,000 Common Stock
Apr 17 2018	BUY Open market or private purchase	$96,034 $3.51 p/Share	27,360 Added 0.17%	16,118,456 Common Stock
Apr 16 2018	BUY Open market or private purchase	$138,083 $3.36 p/Share	41,096 Added 0.25%	16,091,096 Common Stock
Nov 24 2017	BUY Open market or private purchase	$12,000 $1.2 p/Share	10,000 Added 0.06%	16,050,000 Common Stock
Nov 22 2017	BUY Open market or private purchase	$42,592 $1.21 p/Share	35,200 Added 0.22%	16,040,000 Common Stock
Oct 16 2017	BUY Open market or private purchase	$5,184 $1.08 p/Share	4,800 Added 0.03%	16,004,800 Common Stock
Sep 29 2017	BUY Open market or private purchase	$5,988 $0.87 p/Share	6,883 Added 0.04%	16,000,000 Common Stock
Sep 28 2017	BUY Open market or private purchase	$252 $0.84 p/Share	300 Added 0.0%	15,993,117 Common Stock
Sep 27 2017	BUY Open market or private purchase	$81 $0.81 p/Share	100 Added 0.0%	15,992,817 Common Stock
Sep 26 2017	BUY Open market or private purchase	$10,842 $0.8 p/Share	13,552 Added 0.08%	15,992,717 Common Stock
Sep 22 2017	BUY Open market or private purchase	$9,594 $0.78 p/Share	12,300 Added 0.08%	15,979,165 Common Stock
Sep 21 2017	BUY Open market or private purchase	$1,864 $0.79 p/Share	2,360 Added 0.01%	15,966,865 Common Stock
Sep 20 2017	BUY Open market or private purchase	$11,590 $0.76 p/Share	15,250 Added 0.1%	15,964,505 Common Stock
Sep 19 2017	BUY Open market or private purchase	$22,589 $0.75 p/Share	30,119 Added 0.19%	15,949,255 Common Stock
Sep 18 2017	BUY Open market or private purchase	$4,680 $0.78 p/Share	6,000 Added 0.04%	15,919,136 Common Stock
Sep 08 2017	BUY Open market or private purchase	$1,545 $0.75 p/Share	2,060 Added 0.01%	15,913,136 Common Stock
Sep 06 2017	BUY Open market or private purchase	$1,657 $0.74 p/Share	2,239 Added 0.01%	15,911,076 Common Stock
Sep 01 2017	BUY Open market or private purchase	$10,262 $0.74 p/Share	13,867 Added 0.09%	15,908,837 Common Stock
Aug 31 2017	BUY Open market or private purchase	$19,327 $0.77 p/Share	25,100 Added 0.16%	15,894,970 Common Stock
Aug 30 2017	BUY Open market or private purchase	$379 $0.74 p/Share	512 Added 0.0%	15,869,870 Common Stock
Aug 29 2017	BUY Open market or private purchase	$36,000 $0.72 p/Share	50,000 Added 0.31%	15,869,358 Common Stock
Aug 28 2017	BUY Open market or private purchase	$18,484 $0.73 p/Share	25,321 Added 0.16%	15,819,358 Common Stock
Aug 25 2017	BUY Open market or private purchase	$28,746 $0.75 p/Share	38,328 Added 0.24%	15,794,037 Common Stock
Aug 24 2017	BUY Open market or private purchase	$13,961 $0.7 p/Share	19,944 Added 0.13%	15,755,709 Common Stock
Aug 23 2017	BUY Open market or private purchase	$558 $0.62 p/Share	900 Added 0.01%	15,735,765 Common Stock

Also insider at

BBI

Brickell Biotech, Inc. Healthcare

> 10% Shareholder

ALIM

ALIMERA SCIENCES INC Healthcare

> 10% Shareholder

KPRX

KIORA PHARMACEUTICALS INC Healthcare

> 10% Shareholder

SAVA

CASSAVA SCIENCES INC Healthcare

> 10% Shareholder

DFRG

Del Frisco's Restaurant Group, Inc.

> 10% Shareholder

VLRX

Valeritas Holdings Inc.

> 10% Shareholder

BPTH

BIO-PATH HOLDINGS INC Healthcare

> 10% Shareholder

AYTU

AYTU BIOPHARMA, INC Healthcare

Director

ACHV

ACHIEVE LIFE SCIENCES, INC. Healthcare

> 10% Shareholder

AMAG

AMAG PHARMACEUTICALS, INC.

> 10% Shareholder

RSLS

ReShape Weightloss Inc.

> 10% Shareholder

INNV

INNOVUS PHARMACEUTICALS, INC.

> 10% Shareholder

ONTX

Onconova Therapeutics, Inc. Healthcare

> 10% Shareholder

VXRT

Vaxart, Inc. Healthcare

Director

TTPH

TETRAPHASE PHARMACEUTICALS INC

Director

TENX

TENAX THERAPEUTICS, INC. Healthcare

Director

CYTH

Cyclo Therapeutics, Inc. Healthcare

> 10% Shareholder

RSLS

ReShape Lifesciences Inc. Healthcare

> 10% Shareholder

ACL